Rossmore Private Capital’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$718K Hold
4,581
0.06% 184
2026
Q1
$700K Sell
4,581
-146
-3% -$22.4K 0.06% 170
2025
Q4
$652K Buy
4,727
+100
+2% +$13.1K 0.06% 182
2025
Q3
$593K Hold
4,627
0.06% 172
2025
Q2
$560K Hold
4,627
0.07% 170
2025
Q1
$516K Hold
4,627
0.06% 166
2024
Q4
$450K Hold
4,627
0.06% 175
2024
Q3
$532K Hold
4,627
0.07% 166
2024
Q2
$493K Hold
4,627
0.06% 166
2024
Q1
$448K Buy
4,627
+266
+6% +$27.3K 0.06% 175
2023
Q4
$440K Hold
4,361
0.06% 169
2023
Q3
$444K Hold
4,361
0.07% 161
2023
Q2
$440K Sell
4,361
-1,374
-24% -$137K 0.07% 162
2023
Q1
$528K Sell
5,735
-100
-2% -$8.73K 0.08% 152
2022
Q4
$529K Sell
5,835
-380
-6% -$32K 0.08% 154
2022
Q3
$472K Hold
6,215
0.08% 153
2022
Q2
$525K Sell
6,215
-5
-0.1% -$439 0.09% 151
2022
Q1
$546K Buy
6,220
+125
+2% +$10.8K 0.09% 153
2021
Q4
$533K Buy
6,095
+260
+4% +$21.6K 0.08% 153
2021
Q3
$477K Hold
5,835
0.08% 159
2021
Q2
$532K Buy
5,835
+663
+13% +$59K 0.09% 151
2021
Q1
$442K Buy
5,172
+145
+3% +$13K 0.08% 155
2020
Q4
$475K Buy
5,027
+2,645
+111% +$231K 0.1% 146
2020
Q3
$207K Buy
+2,382
New +$206K 0.05% 186
2018
Q1
Sell
-1,205
Closed -$90.7K 306
2017
Q4
$90.7K Buy
+1,205
New +$90.9K 0.09% 135

Other funds holding NVS

Rossmore Private Capital's NVS Position: Q2 2026 in Review

Rossmore Private Capital held its Novartis (NVS) position steady in Q2 2026 at 4,581 shares worth $718K. The position accounts for 0.06% of the portfolio, ranked #184.

Rossmore Private Capital first reported a position in NVS in Q4 2017 and has held it in 25 quarters since. 734 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Rossmore Private Capital held 4,581 shares of Novartis worth $718K as of Q2 2026.
  • Rossmore Private Capital left its Novartis share count unchanged in Q2 2026.
  • Novartis made up 0.06% of Rossmore Private Capital's portfolio in Q2 2026, its #184 holding.
  • Rossmore Private Capital first reported a position in Novartis in Q4 2017 and has held it in 25 quarters since.
  • 734 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Rossmore Private Capital's 13F filing for Q2 2026, filed 31 Jul 2026.